For the malaria parasite to reach the blood of its human host, it must first enter the liver, where only a small number of ...

SBET will not eradicate persistant liver forms of P. vivax and P. ovale, which need treatment with primaquine. However, it is not feasible to include primaquine in SBET regimens as the treatment ...

In a recent article in IJID Regions, researchers assessed the accuracy of rapid diagnostic tests and microscopy for detecting ...

The malaria parasite must first enter the liver to reach the blood of its human host, where only a small number of parasites ...

Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive. Now ...

In a report published in The Lancet Infectious Diseases (Safety and efficacy of PfSPZ Vaccine against malaria in healthy ...

In clinical phase 2 studies, another 8-aminoquinoline, tafenoquine, has been shown to be effective in 86 or 89% when given in 200 or 400 mg weekly doses, respectively, for up to 13 weeks in Kenya ...

Malaria is a mosquito-borne disease that is caused by Plasmodium parasites. Patients with malaria experience flu-like symptoms and, in severe cases, the disease can progress to neurological ...

Malaria has long been a severe health issue ... by various types of parasitic microorganisms such as Plasmodium vivax, P.

It's estimated that severe malaria infection – or plasmodium falciparum – during pregnancy leads to 50,000 deaths and 200,000 stillbirths in Africa every year. Researchers recruited 300 women ...